Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells

por You, Yang, Zheng, Qiongdan, Dong, Yinying, Xie, Xiaoying, Wang, Yaohui, Wu, Sifan, Zhang, Lan, Wang, Yingcong, Xue, Tongchun, Wang, Zhiming, Chen, Rongxin, Wang, Yanhong, Cui, Jiefeng, Ren, Zhenggang
Publicado 2016

Ferroportin downregulation promotes cell proliferation by modulating the Nrf2–miR-17-5p axis in multiple myeloma

por Kong, Yuanyuan, Hu, Liangning, Lu, Kang, Wang, Yingcong, Xie, Yongsheng, Gao, Lu, Yang, Guang, Xie, Bingqian, He, Wan, Chen, Gege, Wu, Huiqun, Wu, Xiaosong, Zhan, Fenghuang, Shi, Jumei
Publicado 2019

DCZ0814 induces apoptosis and G0/G1 phase cell cycle arrest in myeloma by dual inhibition of mTORC1/2

por Kong, Yuanyuan, Li, Bo, Chang, Shuaikang, Gao, Lu, Xu, Zhijian, He, Wan, Yang, Guang, Xie, Bingqian, Chen, Gege, Hu, Liangning, Lu, Kang, Wang, Yingcong, Wu, Xiaosong, Zhu, Weiliang, Shi, Jumei
Publicado 2019

A novel silicone derivative of natural osalmid (DCZ0858) induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma via the JAK2/STAT3 pathway

por Lu, Kang, Li, Bo, Zhang, Hui, Xu, Zhijian, Song, Dongliang, Gao, Lu, Sun, Haiguo, Li, Liping, Wang, Yingcong, Feng, Qilin, Chen, Gege, Hu, Liangning, Wei, Rong, Xie, Yongsheng, Yu, Dandan, Wu, Xiaosong, Zhu, Weiliang, Shi, Jumei
Publicado 2020

A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe

por Hu, Liangning, Li, Bo, Chen, Gege, Song, Dongliang, Xu, Zhijian, Gao, Lu, Xi, Mengyu, Zhou, Jinfeng, Li, Liping, Zhang, Hui, Feng, Qilin, Wang, Yingcong, Lu, Kang, Lu, Yumeng, Bu, Wenxuan, Wang, Houcai, Wu, Xiaosong, Zhu, Weiliang, Shi, Jumei
Publicado 2020

Preclinical validation and phase I trial of 4-hydroxysalicylanilide, targeting ribonucleotide reductase mediated dNTP synthesis in multiple myeloma

por Xie, Yongsheng, Wang, Yingcong, Xu, Zhijian, Lu, Yumeng, Song, Dongliang, Gao, Lu, Yu, Dandan, Li, Bo, Chen, Gege, Zhang, Hui, Feng, Qilin, Zhang, Yong, Hu, Ke, Huang, Cheng, Peng, Yu, Wu, Xiaosong, Mao, Zhiyong, Shao, Jimin, Zhu, Weiliang, Shi, Jumei
Publicado 2022

DCZ3301, a novel cytotoxic agent, inhibits proliferation in diffuse large B-cell lymphoma via the STAT3 pathway

por Sun, Xi, Li, Bo, Xie, Bingqian, Xu, Zhijian, Chang, Gaomei, Tao, Yi, Zhang, Yong, Chang, Shuaikang, Wang, Yingcong, Yu, Dandan, Xie, Yongsheng, Li, Tingye, Wang, Houcai, Chen, Gege, Hu, Liangning, Hou, Jun, Zhang, Yiwen, Xiao, Wenqin, Gao, Lu, Shi, Jumei, Zhu, Weiliang
Publicado 2017

The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13–MAPK–YWHAE signaling pathway

por Wang, Yingcong, Dong, Sanfeng, Hu, Ke, Xu, Li, Feng, Qilin, Li, Bo, Wang, Guangli, Chen, Gege, Zhang, Bibo, Jia, Xinyan, Xu, Zhijian, Gao, Xuejie, Zhang, Hui, Xie, Yongsheng, Lu, Meiling, Chang, Shuaikang, Song, Dongliang, Wu, Xiaosong, Jia, Qi, Zhu, Huabin, Zhou, Jinfeng, Zhu, Weiliang, Shi, Jumei
Publicado 2023

Preclinical activity of DCZ3301, a novel aryl-guanidino compound in the therapy of multiple myeloma

por Gao, Minjie, Li, Bo, Sun, Xi, Zhou, Yunfei, Wang, Yingcong, Tompkins, Van S., Xu, Zhijian, Indima, Nekitsing, Wang, Houcai, Xiao, Wenqin, Gao, Lu, Chen, Gege, Wu, Huiqun, Wu, Xiaosong, Kong, Yuanyuan, Xie, Bingqian, Zhang, Yiwen, Chang, Gaomei, Hu, Liangning, Yang, Guang, Dai, Bojie, Tao, Yi, Zhu, Weiliang, Shi, Jumei
Publicado 2017